CytomX Therapeutics Stock (NASDAQ: CTMX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 50.00 / 6.90M |
Day Range | - - - |
52 Wk Range | 1.04 - 5.85 |
Market Cap | $106.76M |
P/E Ratio | 6.57 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 10.41% |
Days to Cover | 3.86 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CytomX Therapeutics (NASDAQ:CTMX) through any online brokerage.
Other companies in CytomX Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Armata Pharmaceuticals (AMEX:ARMP), FibroGen (NASDAQ:FGEN), Vistagen Therapeutics (NASDAQ:VTGN) and Adicet Bio (NASDAQ:ACET).
There is no analysis for CytomX Therapeutics.
CytomX Therapeutics has a consensus price target of $6.29.
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $1.3701 last updated July 19, 2024 at 6:39 PM EDT.
There are no upcoming dividends for CytomX Therapeutics.
CytomX Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for CytomX Therapeutics.
CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.